HealthDay News — Louisiana has reported what appears to be the state’s first case of bird flu.

The FDA has granted Breakthrough Therapy designation to the combination of tobevibart and elebsiran for the treatment of chronic hepatitis delta in adults.

In news that suggests the US opioid epidemic may be easing, drug overdose deaths fell 17% between July 2023 and July 2024.

Researchers observed associations for acetaminophen use with increased risks for peptic ulcer bleeding, uncomplicated peptic ulcers, lower gastrointestinal bleeding, heart failure, hypertension, and ...

Long-term outcomes in patients with tuberculosis may be improved with the enhancement of cardiovascular disease screening and risk management strategies. Among people with vs without tuberculosis (TB) ...

Xalnesiran plus an immunomodulator results in a substantial percentage of patients with hepatitis B surface antigen loss.

Higher caregiving stress among reproductive-age Black women is associated with incident hypertension, according to study findings.

Researchers found a significant reduction in antibiotic duration from random assignment to 28 days for those in the daily procalcitonin-guided protocol vs standard care. HealthDay News — Sepsis care ...

Patients who received the original monovalent mRNA COVID-19 vaccine were less likely than unvaccinated patients to be hospitalized for COVID-19-associated VTE.

The FDA has granted Fast Track designation to 2 investigational combination vaccines to prevent influenza and COVID-19 infections in adults 50 years and older.

The ACIP recommendations have been updated for the meningococcal serogroup B MenB-4C vaccine (Bexsero), in accordance with the updated US FDA label.

Only 37% of children had received the influenza vaccine as of November 30th, down from 43% at the same time last year.